Sanford Zweifach
Sanford Zweifach is a senior executive with 30 years in the life sciences industry. Mr. Zweifach has served as the Founder and President of Pelican Consulting Group, a biotechnology consulting firm, since December 2019. Prior to Pelican Consulting Group, Mr. Zweifach founded and served as Chief Executive Officer of Nuvelution Pharma, Inc., a pharmaceutical company, from June 2015 to November 2019.In addition to serving on the board of Carisma Therapeutics Inc., Mr. Zweifach currently is the President and CBO and board member of IMIDomics, Inc,, and serves on the boards of directors of Essa Pharma Inc. (Nasdaq: EPIX) and Compugen Ltd. (Nasdaq: CGEN). Mr. Zweifach received a B.A. in Biology from University of California San Diego and a M.S. in Human Physiology from University of California Davis.